Veterinary Antibiotics market to surge $ 2.2 billion by 2031 | Exclusive report by DatamIntelligence

According to DataM Intelligence, the Veterinary Antibiotics market reached US$ 1.5 billion in 2023 and is projected to expand to US$ 2.2 billion by 2031, reflecting a CAGR of 4.5% during the forecast period of 2024-2031. Veterinary antibiotics are critical in treating and preventing bacterial, parasitic, and other infections in both livestock and companion animals, supporting healthier animals and enhanced productivity.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/veterinary-antibiotics-market?sp

United States: Recent Industry Developments

✅ In September 2025, Zoetis launched a next-generation veterinary antibiotic for livestock, focusing on broad-spectrum bacterial infections with improved safety and reduced antimicrobial resistance risk.

✅ In August 2025, Elanco expanded its veterinary antibiotic portfolio with new oral and injectable formulations for companion animals, targeting skin, respiratory, and urinary tract infections.

✅ In July 2025, Merck Animal Health introduced precision-targeted antibiotics for poultry and swine, enhancing efficacy while minimizing environmental and resistance concerns.

✅ In June 2025, Bayer Animal Health invested in R&D for next-generation veterinary antimicrobials with optimized dosing and delivery systems to support sustainable livestock health.

Japan: Recent Industry Developments

✅ In September 2025, Sumitomo Pharma launched new veterinary antibiotics for livestock and companion animals, emphasizing efficacy, safety, and resistance management tailored to Japanese regulations.

✅ In August 2025, Kyoritsu Seiyaku expanded its antibiotic product line for domestic veterinary use, addressing infections in pets and farm animals with enhanced bioavailability.

✅ In July 2025, Meiji Seika Pharma introduced targeted antibiotics for poultry and swine, focusing on reducing treatment duration while maintaining animal health and productivity.

✅ In June 2025, Nihon Nohyaku invested in R&D for innovative veterinary antibiotics incorporating novel delivery methods and reduced environmental impact for livestock applications.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/veterinary-antibiotics-market?sp

Rising Demand for Veterinary Antibiotics and Industry Dynamics

The increasing prevalence of zoonotic diseases has amplified the need for effective veterinary antibiotics. These diseases, which can be transmitted from animals to humans, present significant risks to both public health and livestock management. According to global health reports, zoonotic infections are responsible for billions of human cases and millions of deaths annually. This heightened awareness has prompted greater investments in preventive and therapeutic treatments within the veterinary sector.

However, the market also faces challenges. Overuse of antibiotics has led to growing concerns over antimicrobial resistance, prompting stricter regulations and a push for responsible antibiotic usage. Regulatory authorities, particularly in developed nations, are enforcing guidelines to ensure sustainable antibiotic use while maintaining the effectiveness of treatments.

Market Segmentation Insights

The veterinary antibiotics market is analyzed across multiple dimensions: product type, animal type, route of administration, and end user.

By Product Type: The market includes anti-parasitic, anti-bacterial, non-steroidal anti-inflammatory drugs (NSAIDs), and others. Among these, anti-bacterial antibiotics dominate with a 41.3% share, reflecting their essential role in preventing and treating bacterial infections across livestock and companion animals. Anti-parasitic agents are increasingly important in livestock management, while NSAIDs address inflammation and pain management in both companion animals and livestock.

By Animal Type: Veterinary antibiotics are used extensively for companion animals and livestock animals. Companion animals such as dogs and cats drive demand for advanced therapeutic treatments, including monoclonal antibodies and chewable formulations. Livestock applications focus on disease prevention, productivity improvement, and ensuring food safety, especially in large-scale farming operations.

By Route of Administration: The market offers oral, injection, topical, and other routes. Oral medications remain popular for ease of administration in both large and small animals, whereas injections are preferred for rapid action and severe infections. Topical antibiotics address skin infections and localized conditions, enhancing therapeutic outcomes.

By End User: The primary end users include veterinary clinics, veterinary hospitals, and other specialized facilities. Veterinary hospitals typically demand higher-value, prescription-based antibiotics for complex treatments, while clinics focus on routine treatments and preventive care.

Regional Market Analysis: USA and Japan

United States: North America holds approximately 41.04% of the global veterinary antibiotics market, driven by FDA approvals, stringent veterinary standards, and the growing number of veterinary healthcare centers. In October 2023, the FDA approved bedinvetmab injection and Oclacitinib chewable tablets for dogs, enhancing treatment options for osteoarthritis and allergic conditions. Furthermore, in April 2024, the FDA approved Pradalex (pradofloxacin injection) for respiratory diseases in cattle and swine, reflecting ongoing innovation and regulatory support in the US veterinary market.

Japan: Japan represents a key market in Asia-Pacific, supported by advanced veterinary practices and government initiatives promoting animal health. Rising awareness of zoonotic disease prevention and the adoption of modern veterinary antibiotics have contributed to steady growth. Recent collaborations between local pharmaceutical companies and global players have further expanded product offerings and therapeutic solutions in companion and livestock segments.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=veterinary-antibiotics-market?sp

Leading Players in the Veterinary Antibiotics Market

The competitive landscape is shaped by prominent global companies:

1. Bayer AG: A key player offering a diverse portfolio of veterinary antibiotics, Bayer emphasizes innovation in anti-bacterial and anti-parasitic therapies, with a focus on livestock productivity and companion animal health.

2. Boehringer Ingelheim GmbH: Known for its research-driven approach, Boehringer Ingelheim delivers advanced formulations in anti-parasitic and NSAID segments, strengthening its market position across Europe, the USA, and Asia.

3. Ceva Sante Animale S.A.: Ceva specializes in comprehensive veterinary solutions, including injectable antibiotics and oral therapies for livestock and companion animals, leveraging partnerships for global expansion.

4. Dechra Pharmaceuticals PLC: Dechra focuses on veterinary hospitals and clinics, offering targeted therapies in anti-bacterial and anti-inflammatory categories, with strong regulatory compliance and R&D investments.

5. Elanco Animal Health (Eli Lilly Company): Elanco provides innovative anti-parasitic, anti-bacterial, and NSAID solutions, emphasizing disease prevention in both livestock and companion animals, supported by strategic collaborations worldwide.

Other notable players include Merck & Co. Inc., Sanofi S.A., Vetoquinol S.A., Virbac SA, and Zoetis, Inc., all contributing to the competitive dynamics through continuous product innovation and geographic expansion.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.